Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

NCT00004072

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • MetroHealth Medical Center Cleveland, Ohio, United States
View Trial Details
Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations
  • Mt. Sinai Medical Center New York, United States
  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health Sciences University Portland, Oregon, United States
View Trial Details
Completed

IFM 99-02 Thalidomide in Myeloma

NCT00222053

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Médecine Interne, CHU Purpan Toulouse, France
  • Médecine Interne, Hôpital Rangueil Toulouse, France
  • Rhumatologie, CHU Purpan Toulouse, France
  • Rhumatologie, CHU Rangueil Toulouse, France
View Trial Details

Related conditions